Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health reform fix-it bill becomes law

This article was originally published in The Gray Sheet

Executive Summary

President Obama signs the final piece of health reform legislation March 30. The Health Care and Education Reconciliation Act includes a number of fixes to the Senate-written health reform bill that the president signed on March 23, including a 2.3% excise tax on devices that begins in 2013 (1"The Gray Sheet" March 29, 2010). The law, which aims to provide health insurance to an additional 32 million people, also establishes a Patient-Centered Outcomes Research Institute to conduct comparative effectiveness research, reduces advanced imaging services payments, and requires device firms to track and report payments to physicians

You may also be interested in...



Device Tax Will Present "Manageable" Challenges, Analysts Say

The final health care reform device industry tax provision, while presenting a challenge, will be manageable by the sector at large, according to industry analysts

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028700

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel